| Literature DB >> 33593777 |
Lena Janita Skarshaug1, Silje Lill Kaspersen2,3, Johan Håkon Bjørngaard2,4, Kristine Pape2.
Abstract
OBJECTIVES: Patients may benefit from continuity of care by a personal physician general practitioner (GP), but there are few studies on consequences of a break in continuity of GP. Investigate how a sudden discontinuity of GP care affects their list patients' regular GP consultations, out-of-hours consultations and acute hospital admissions, including admissions for ambulatory care sensitive conditions (ACSC).Entities:
Keywords: epidemiology; health & safety; primary care; public health
Year: 2021 PMID: 33593777 PMCID: PMC7888374 DOI: 10.1136/bmjopen-2020-042391
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Illustration of study design and timeline for (A) study population and GPs, (B) definition of control period (12 months of stable GP activity on own patient list), exposure time periods during (3-month period defined discontinuity with at least 2 months with no/low activity (X)), 1–6 months after discontinuity and 7–12 months after discontinuity and (C) patient outcome assessment (four outcomes) in our four defined periods. ACSC, ambulatory care sensitive conditions; GP, general practitioner; OOH, out-of-hours.
Study sample with baseline characteristics of selected GPs with an episode of discontinuity in an earlier stable practice and their list patients (2007–2017)
| N | % | |
| GP characteristics* | ||
| Total | 2560 | 100 |
| GP sex | ||
| Female | 1084 | 42 |
| Male | 1476 | 58 |
| GP age at discontinuity | ||
| <30 | 22 | 1 |
| 30–39 | 1010 | 39 |
| 40–49 | 548 | 21 |
| 50–59 | 431 | 17 |
| 60+ | 549 | 21 |
| GP in group practice | 2244 | 88 |
| GP activity before discontinuity | ||
| Registered list size—mean number of patients (range) | 1126 | 500–2483 |
| Mean no of ordinary patient consultations during 12 months before discontinuity (range) | 2657 | 1000–10 530 |
| GP activity 12 months after discontinuity | ||
| Registered with same list ID as before | 1586 | 62 |
| Registered with same list ID as before and active (>10 consultations) | 1112 | 43 |
| Registered with same list ID as before and normal activity (number of consultations≥75% compared with 12 months before discontinuity) | 813 | 32 |
| Patient episode characteristics* | ||
| Patient episodes† | 2 862 717 | 100 |
| Sex | ||
| Female | 1 441 798 | 50.4 |
| Male | 1 420 919 | 49.6 |
| Age groups | ||
| 0–18 | 614 576 | 21.5 |
| 19–44 | 1 026 774 | 35.9 |
| 46–64 | 729 031 | 25.5 |
| 65–79 | 339 833 | 11.9 |
| 80+ | 152 503 | 5.3 |
| Educational level‡ | ||
| Primary | 680 098 | 27.8 |
| Secondary | 1 014 323 | 41.5 % |
| Tertiary | 752 697 | 30.8 % |
| Geography§ | ||
| Municipality <2000 inhabitants | 55 576 | 2 (of total) |
| 10 most populated municipalities | 892 857 | 31 (of total) |
*Patient and GP characteristics were identified 12 months before the identified discontinuity, unless otherwise stated.
†Incidents of discontinuity of care. Some patient could experience several episodes of discontinuity during our observation time, and hence be counted more than once.
‡Educational level measured in 2016.
§Municipality in which the patient’s GP was registered. Municipality size per 2. quarter of 2019.
ACSC, ambulatory care sensitive conditions; GP, general practitioner.
Estimated ORs with 95% CIs for one or more monthly GP consultations, out-of-hours service consultations, acute hospital admissions and hospital admissions for ACSC during (3-month period) and after (1–6 months after and 7–12 months after) a sudden discontinuity of GP care, compared with a 12-month stable control period before the discontinuity. GEE analyses based on repeated monthly measurements within patient within GP, with separate analyses for each patient age group and adjustment for month/time, calendar month, calendar year, patient age and sex (2007–2017)
| 0–18 years | 19–44 years | 45–64 years | 65–79 years | 80+ years | ||||||
| OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| Monthly GP consultations (1 or more) | ||||||||||
| Control period (12-month period before discontinuity) | 1.00 | ref | 1.00 | ref | 1.00 | ref | 1.00 | ref | 1.00 | ref |
| Discontinuity (3-month period) | 0.96 | (0.95 to 0.96) | 0.97 | (0.97 to 0.98) | 0.96 | (0.95 to 0.96) | 0.95 | (0.95 to 0.96) | 0.96 | (0.96 to 0.97) |
| After discontinuity I (1–6 months after) | 0.97 | (0.96 to 0.98) | 1.00 | (0.99 to 1.00) | 1.00 | (1.00 to 1.01) | 1.01 | (1.00 to 1.02) | 1.03 | (1.01 to 1.04) |
| After discontinuity II (7–12 months after) | 0.97 | (0.96 to 0.99) | 1.00 | (0.99 to 1.01) | 1.00 | (0.99 to 1.01) | 1.01 | (1.00 to 1.02 | 1.01 | (0.99 to 1.02) |
| Monthly out-of-hours consultations (1 or more) | ||||||||||
| Control period (12-month period before discontinuity) | 1.00 | ref | 1.00 | ref | 1.00 | ref | 1.00 | ref | 1.00 | ref |
| Discontinuity (3-month period) | 1.00 | (0.98 to 1.02) | 1.04 | (1.02 to 1.05) | 1.02 | (1.01 to 1.04) | 1.05 | (1.02 to 1.07) | 1.06 | (1.02 to 1.09) |
| After discontinuity I (1–6 months after) | 0.98 | (0.96 to 1.00) | 1.03 | (1.01 to 1.05) | 1.01 | (0.99 to 1.03) | 1.06 | (1.02 to 1.09) | 1.07 | (1.03 to 1.11) |
| After discontinuity II (7–12 months after) | 0.97 | (0.95 to 1.00) | 1.02 | (1.00 to 1.05) | 0.99 | (0.96 to 1.03) | 1.06 | (1.02 to 1.11) | 1.06 | (1.00 to 1.12) |
| Monthly acute hospital admissions (one or more) | ||||||||||
| Control period (12-month period before discontinuity) | 1.00 | ref | 1.00 | ref | 1.00 | ref | 1.00 | ref | 1.00 | ref |
| Discontinuity (3-month period) | 1.02 | (0.97 to 1.07) | 1.03 | (1.00 to 1.05) | 1.01 | (0.99 to 1.04) | 1.02 | (1.00 to 1.05) | 1.03 | (1.00 to 1.06) |
| After discontinuity I (1–6 months after) | 1.04 | (0.98 to 1.10) | 1.02 | (0.99 to 1.05) | 1.01 | (0.98 to 1.05) | 1.04 | (1.01 to 1.08) | 1.04 | (1.00 to 1.08) |
| After discontinuity II (7–12 months after) | 1.10 | (1.02 to 1.20) | 1.02 | (0.98 to 1.07) | 1.01 | (0.97 to 1.06) | 1.04 | (0.99 to 1.09) | 1.02 | (0.97 to 1.07) |
| Monthly ACSC hospital admissions (1 or more) | ||||||||||
| Control period (12-month period before discontinuity) | 1.00 | ref | 1.00 | ref | 1.00 | ref | 1.00 | ref | 1.00 | ref |
| Discontinuity (3-month period) | 0.91 | (0.82 to 1.02) | 1.05 | (0.96 to 1.15) | 1.02 | (0.95 to 1.09) | 1.03 | (0.98 to 1.09) | 1.06 | (1.00 to 1.12) |
| After discontinuity I (1–6 months after) | 0.97 | (0.85 to 1.10) | 1.07 | (0.96 to 1.19) | 1.04 | (0.96 to 1.12) | 1.07 | (1.01 to 1.14) | 1.09 | (1.02 to 1.16) |
| After discontinuity II (7–12 months after) | 0.99 | (0.83 to 1.19) | 1.05 | (0.90 to 1.22) | 1.02 | (0.91 to 1.14) | 1.11 | (1.01 to 1.21) | 1.04 | (0.94 to 1.14) |
ACSC, ambulatory care sensitive conditions; GEE, generalised estimation equation; GP, general practitioner.